WeissLaw LLP reminds SQ, TBIO, KIN and MNR shareholders of its ongoing investigations

0

NEW YORK, August 10, 2021 / PRNewswire / –

If you own shares in any of the companies listed above and
would like to discuss our inquiries or have questions regarding
this notice or your rights or interests, please contact:

Joshua Rubin, Esq.
WeissLaw LLP
1500 Broadway, 16e Ground
new York, NY 10036
(212) 682-3025
(888) 593-4771
[email protected]

Square, Inc. (NYSE: SQ)

WeissLaw LLP investigates possible breaches of fiduciary duty and other violations of law by the Board of Directors of Square, Inc. (NYSE: SQ) in connection with the proposed acquisition by the company of Afterpay Limited (“Afterpay”). Under the terms of the agreement, SQ will issue Class A common shares of SQ to shareholders of Afterpay, who will receive 0.375 shares of SQ for each share of Afterpay they hold. If you own SQ stock and would like to discuss this investigation or your rights, please call us or visit our website: https://www.weisslaw.co/news-and-cases/sq

Translate Bio, Inc. (NASDAQ: TBIO)

WeissLaw LLP investigates possible breaches of fiduciary duty and other violations of law by the Board of Directors of Translate Bio, Inc. (NASDAQ: TBIO) in the context of the proposed acquisition of the company by Sanofi (“Sanofi”) via a takeover bid. Under the terms of the merger agreement, the shareholders of the company will receive $ 38.00 in cash for each common share of TBIO they hold. If you own TBIO shares and would like to discuss this investigation or your rights, please call us or visit our website: https://www.weisslaw.co/news-and-cases/tbio

Kindred Biosciences, Inc. (NASDAQ: KIN)

WeissLaw LLP investigates possible breaches of fiduciary duty and other violations of law by the Board of Directors of Kindred Biosciences, Inc. (NASDAQ: KIN) in connection with the proposed acquisition of the company by Elanco Animal Health Incorporated. Under the terms of the merger agreement, the shareholders of the company will receive $ 9.25 per share in cash for each KIN common share they hold. If you own KIN shares and would like to discuss this investigation or your rights, please call us or visit our website: https://www.weisslaw.co/news-and-cases/kin

Monmouth Real Estate Investment Company (NYSE: MNR)

WeissLaw LLP investigates possible breaches of fiduciary duty and other violations of law by the Board of Directors of Monmouth Real Estate Investment Company (NYSE: MNR) in connection with the proposed acquisition of the company by Equity Commonwealth (“Equity”). Under the merger agreement, shareholders of MNR will receive 0.67 common shares of Equity for each share of MNR they hold, which is the implied merger consideration per share of $ 17.52 equity-based August 9, 2021 closing price of $ 26.15. If you own shares of MNR and would like to discuss this investigation or your rights, please call us or visit our website: https://www.weisslaw.co/news-and-cases/monmouth-real-estate-investment-corporation-investigation

SOURCE WeissLaw LLP

Related links

http://weisslawllp.com


Source link

Leave A Reply

Your email address will not be published.